Health ❯ Healthcare ❯ Clinical Trials

Preclinical Studies

Vaccine Efficacy Combination Therapy Phase 1 Trials Mouse Models Patient Safety NAD-Boosting Compounds Immunotherapy FORCE Platform Drug Development Therapeutic Approaches Cancer Treatment Strategies Imaging Agents Drug Resistance Drug Efficacy Biomarkers Therapeutic Innovations Telomir-1 Chemotherapy-Refractory Cancer Animal Testing Tracer Evaluation Disease Modification Immunotherapy Efficacy Animal Models Cancer Therapies Therapeutic Efficacy Xenograft Models Drug Safety Bladder Cancer Treatments Treatment Outcomes

Psilocybin Prevents Chemotherapy Nerve Damage in Mice

Researchers report that two pre-chemotherapy doses preserved mitochondrial trafficking through 5‑HT2A receptors, and the result has prompted a planned Phase II trial.

NTX-301 Reprograms Epigenetics to Fight Treatment-Resistant AML

Engineered CAR T Cells Targeting MUC16 Control Bladder Tumors in Mice

Akari’s AKTX-101 Shows Preclinical Synergy With KRAS Inhibitor as Stock Soars

ARPA-H Advances Three Knee Osteoarthritis Regeneration Projects Toward Human Trials

DNA Origami Vaccine Scaffold Sharply Focuses HIV Immune Response in Preclinical Study

Triple Therapy Counters Endocrine Resistance in ER+ Breast Cancer in Preclinical Study

Lung Tumors Reprogram Bone Marrow Progenitors as NRF2 Emerges as a Target

Dual-Mode 18F Tracer Shows Preclinical Promise for Image-Guided Prostate Cancer Surgery

Study Finds NAD Decline Drives Age-Related CAR-T Cell Therapy Failures